DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Pharmaceuticals & Biotech
Updated 1m ago
MSRM logo

Mushrooms Inc.OTCPK:MSRM Stock Report

Market Cap US$640.5k
Updated 1m ago
Share Price
n/a
1Y-38.0%
7D8.2%
1D8.2%
Portfolio Value
​
View

Mushrooms Inc.

OTCPK:MSRM Stock Report

Market Cap: US$640.5k

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Mushrooms (MSRM) Stock Overview

Mushrooms Inc. intends to acquire and merge with small, mid-size, and development stage companies focused on the mushroom industry. More details

MSRM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the US market

Latest financial reports are more than a year old

Does not have a meaningful market cap ($640K)


MSRM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW437,476 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
437,476 investors already sharing narratives
US$
Current Price
US$0.014547.7% overvalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-132k48k2016201920222025202620282031Revenue US$48.0kEarnings US$7.1k
Advanced
View all narratives

Mushrooms Inc. Competitors

Altamira Therapeutics

Symbol: OTCPK:CYTO.F
Market cap: US$405.0k

China SXT Pharmaceuticals

Symbol: NasdaqCM:SXTC
Market cap: US$2.8m

CBD Life Sciences

Symbol: OTCPK:CBDL
Market cap: US$1.2m

Petros Pharmaceuticals

Symbol: OTCPK:PTPI
Market cap: US$339.0k

Price History & Performance

Summary of share price highs, lows and changes for Mushrooms
Historical stock prices
Current Share PriceUS$0.014
52 Week HighUS$0.039
52 Week LowUS$0.01
Beta0
1 Month Change1.06%
3 Month Change-20.83%
1 Year Change-38.04%
3 Year Change-90.10%
5 Year Change-96.44%
Change since IPO-99.90%

Recent News & Updates

Recent updates

Shareholder Returns

MSRMUS PharmaceuticalsUS Market
7D8.2%-4.0%-2.2%
1Y-38.0%43.7%13.1%

Return vs Industry: MSRM underperformed the US Pharmaceuticals industry which returned 45.8% over the past year.

Return vs Market: MSRM underperformed the US Market which returned 14.8% over the past year.

Price Volatility

Is MSRM's price volatile compared to industry and market?
MSRM volatility
MSRM Average Weekly Movement31.9%
Pharmaceuticals Industry Average Movement8.8%
Market Average Movement6.9%
10% most volatile stocks in US Market15.4%
10% least volatile stocks in US Market2.9%

Stable Share Price: MSRM's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: MSRM's weekly volatility has decreased from 41% to 32% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2002n/aKimberly Carlsonwww.mushroomsinc.com

Mushrooms Inc. intends to acquire and merge with small, mid-size, and development stage companies focused on the mushroom industry. The company was formerly known as Marijuana Strategic Ventures Inc. and changed its name to Mushrooms Inc. in October 2022. Mushrooms Inc. was founded in 2002 and is based in Estero, Florida.

Mushrooms Inc. Fundamentals Summary

How do Mushrooms's earnings and revenue compare to its market cap?
MSRM fundamental statistics
Market capUS$640.47k
Earnings (TTM)-US$132.42k
Revenue (TTM)US$47.99k
0.0x
P/S Ratio
0.0x
P/E Ratio

Is MSRM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MSRM income statement (TTM)
RevenueUS$47.99k
Cost of RevenueUS$30.99k
Gross ProfitUS$17.00k
Other ExpensesUS$149.42k
Earnings-US$132.42k

Last Reported Earnings

Mar 31, 2011

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did MSRM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/11 04:57
End of Day Share Price 2026/09/08 00:00
Earnings2011/03/31
Annual Earnings2010/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mushrooms Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide